Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2026-01-09 @ 8:28 AM
Study NCT ID:
NCT05572333
Status:
COMPLETED
Last Update Posted:
2023-11-29
First Post:
2022-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial to Investigate the Safety and Tolerability of EP395 in Patients With COPD
Sponsor:
EpiEndo Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EP395-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |